CD160 Polyclonal Antibody

Background:
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine.

Research Area: Cardiovascular, Immunology

Synonyms:
BY55, BY55, CD160, CD160 antigen [Precursor], CD160 antigen, CD160 delta Ig, CD160 molecule, CD160 transmembrane isoform, FLJ46513, Natural killer cell receptor BY55, Natural killer cell receptor, immunoglobulin superfamily member, NK1, NK28

Immunogen: Recombinant protein of human CD160

Swissprot: O95971
Gene Accession: BC014465

Calculated MW: 20 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.7 mg/mL
Dilution: WB 1:500-1:2000, IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-69452